Emil Freireich, MD, Oral History Interview, July 30, 2001
Files
Download Navigation Materials and Full Transcript (168 KB)
Loading...
Description
Major Topics Covered:
- Research: the continuous flow-blood separator; innovations in chemotherapy and combination therapy ;
- Collaborations with Dr. Emil Frei, III;
- The Department of Developmental Therapeutics;
- Building the culture of clinical research; training clinical researchers and physician-scientists ;
- History of cancer medicine, clinical research, translational research and education;
- Institutional politics as they influenced: Developmental Therapeutics, individual investigators, the standing of clinical research, the education of physician scientists;
Interview Chapters
Chapter 09: At the NIH: Studying Infection in Leukemic Patients [early 60s]
Chapter 10: At the NIH: Vincristine, a Cure for Childhood Leukemia, and VAMP
Chapter 11: Leaving the NIH for a Turbulent Research Environment at MD Anderson
Chapter 12: The Lay of the Land: Developmental Therapeutics and MD Anderson in 1965
Chapter 13: Getting to Work, Diving into Controversy, and Studies of POMP
Chapter 14: Developmental Therapeutics in the Midst of Opposition to Systemic Treatment of Cancer
Identifier
FreireichJ_02_20010730
Publication Date
7-30-2001
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Freireich, Emil J. MD and Brunet, Lesley W., "Emil Freireich, MD, Oral History Interview, July 30, 2001" (2001). Interview Sessions. 24.
https://openworks.mdanderson.org/mchv_interviewsessions/24
Conditions Governing Access
Redacted
About the Interview
About the Interview Subject
Dr. Emil J Freireich (b. 16 March 1927, in Chicago, Illinois) came to MD Anderson in 1965 to serve as Chief of Research (Hematology) in the Department of Development Therapeutics. He was appointed Professor in the Department of Leukemia in the Division of Cancer Medicine.
A pioneer in clinical oncology research and the development of new treatments, Dr. Freireich is best known for developing an effective treatment –effectively a cure-- for childhood acute lymphoblastic leukemia. Freireich worked closely with Emil Frei, MD, and the collaborators developed the first combination chemotherapy treatments shown to be effective against childhood leukemia.
Dr. Freireich served as head of MD Anderson’s Department of Developmental Therapeutics from 1972-1983, when he became Chairman of the Department of Hematology (1983-1985). He served as Director of the Adult Leukemia Research Program (1985-2015). He served as Special Medical Education Director of Educational Programs in the Division of Academic Affairs (2000-2015). In 2014, Dr. Freireich was honored as a Fellow of the American Association for Cancer Research. He retired in 2016.